SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-17-000463
Filing Date
2017-06-26
Accepted
2017-06-23 20:15:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13DA BY PHARMSTANDARD INTERNATIONAL S.A. FOR ARGOS THERAPEUTICS, INC. s13da_062217-argostherap.htm SC 13D/A 85623
  Complete submission text file 0000904454-17-000463.txt   87101
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88006 | Film No.: 17928752
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530
Business Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530 352 24840131
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A